	US 12,357,584 B2
	Composition and method of controlling infectious diseases with functional fragrances
Daryl L. Thompson, Winter Haven, FL (US); Nicholas A. Van Rees, Kirkwood, MO (US); and Thomas A. Meyer, St. Louis, MO (US)
Assigned to GLOBAL BIOLIFE INC., Bethesda, MD (US)
Filed by GLOBAL BIOLIFE INC., Bethesda, MD (US)
Filed on Dec. 7, 2018, as Appl. No. 16/212,966.
Prior Publication US 2020/0179299 A1, Jun. 11, 2020
Int. Cl. A61K 31/015 (2006.01); A61K 9/08 (2006.01); A61K 31/045 (2006.01); A61K 31/05 (2006.01); A61K 31/085 (2006.01); A61K 31/11 (2006.01); A61K 31/35 (2006.01); A61P 31/04 (2006.01); A61P 31/16 (2006.01)

CPC A61K 31/015 (2013.01) [A61K 9/08 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/085 (2013.01); A61K 31/11 (2013.01); A61K 31/35 (2013.01); A61P 31/04 (2018.01); A61P 31/16 (2018.01)]

16 Claims

1. A composition comprising:

0.25-7% β-pinene,

0.25-25% borneol,

5-30% cinnamic aldehyde,

0.25-25% citral,

0.25-5% d-limonene,

1-10% eucalyptol,

1-15% eugenol,

10-30% farnesol,

25-50% linalool,

0.5-7% thymol, and

2-7% vanillin.